Literature DB >> 9306904

Role of fever in infection: has induced fever any therapeutic potential in HIV infection?

R S Morton1, S Rashid.   

Abstract

Ancient societies had no rational understanding of fever. The Greeks were the first to recognise that it may be part of nature's method of effecting cure in some diseases. How best to assist nature went through many trials and errors. Appreciation of the prognostic value of fever and how it may be controlled was slow to appear. That there was a place in the therapeutic arsenal for induced fever came only with the 20th century. Finding a suitable, safe, and satisfactory means came slowly. The curative power of well controlled and reproducible levels of fever was proved by the arrest of one deadly and incurable complication of a sexually transmitted disease in the first half of this century. The purpose of this review is to promote discussion and, hopefully, well ordered laboratory and clinical trials aimed at learning whether or not induced fevers have a place in the care of patients with HIV/AIDS.

Entities:  

Mesh:

Year:  1997        PMID: 9306904      PMCID: PMC1195825          DOI: 10.1136/sti.73.3.212

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  10 in total

1.  Studies on the cause of fever.

Authors:  W B WOOD
Journal:  N Engl J Med       Date:  1958-05-22       Impact factor: 91.245

2.  Survival of HIV-1 activity after disinfection, temperature and pH changes, or drying.

Authors:  E Tjøtta; O Hungnes; B Grinde
Journal:  J Med Virol       Date:  1991-12       Impact factor: 2.327

3.  HIV research: a need to focus on the right target.

Authors:  J A Levy
Journal:  Lancet       Date:  1995-06-24       Impact factor: 79.321

Review 4.  Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation.

Authors:  T Nowak; M Niedrig; D Bernhardt; J Hilfenhaus
Journal:  Dev Biol Stand       Date:  1993

5.  Inactivation of human immunodeficiency virus type I in human milk: effects of intrinsic factors in human milk and of pasteurization.

Authors:  S L Orloff; J C Wallingford; J S McDougal
Journal:  J Hum Lact       Date:  1993-03       Impact factor: 2.219

6.  Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus.

Authors:  M Morita; T Suzuki; K Nakajima; C Shiozawa; M J Gill; H Hoshino
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

7.  Sex differences in endocrine response to hyperthermia in sauna.

Authors:  D Jezová; R Kvetnanský; M Vigas
Journal:  Acta Physiol Scand       Date:  1994-03

8.  Systemic hyperthermia in the treatment of HIV-related disseminated Kaposi's sarcoma. Long-term follow-up of patients treated with low-flow extracorporeal perfusion hyperthermia.

Authors:  K Alonso; P Pontiggia; A Sabato; G Calvi; F C Curto; E de Bartolomei; C Nardi; P Cereda
Journal:  Am J Clin Oncol       Date:  1994-08       Impact factor: 2.339

9.  Effect of whole-body hyperthermia on AIDS patients with Kaposi's sarcoma: a pilot study.

Authors:  C R Steinhart; S R Ash; C Gingrich; D Sapir; G N Keeling; M B Yatvin
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-03-01

10.  Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis.

Authors:  C Pennypacker; A S Perelson; N Nys; G Nelson; D I Sessler
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.